Ophthalmology Times Europe Newsletter

To view this email as a web page, click here.

ISSUE ALERT

Volume 14, Issue 10

Check out the digital edition!

Top ophthalmic challenges for 2019

As the year 2018 winds to a close, thoughts begin to turn to the next challenges for ophthalmology in the new year.

Intestinal microbiome proposed as potential therapeutic target for AMD

Dr Sebastian Wolf describes accumulating evidence pointing to a role of the gut microbiome in the development of age-related macular degeneration.

High- versus medium-add multifocal IOLs

Medium-add multifocal addresses the most likely source of dissatisfaction with contemporary multifocal IOLs: Intermediate vision.

*ZEISS AT LISA tri and ZEISS AT LARA are not available for sales in the US.

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.